Presbycusis and Hearing Preservation in Observed Vestibular Schwannomas

Otol Neurotol. 2023 Sep 1;44(8):817-821. doi: 10.1097/MAO.0000000000003947. Epub 2023 Jul 7.

Abstract

Objective: We reviewed a cohort of patients with untreated sporadic vestibular schwannoma (VS) and examined the relationship between high-frequency hearing loss (HFHL) in the non-VS ear and long-term hearing outcomes in the VS-affected ear. We hypothesized that the progression of HFHL is associated with accelerated hearing decline in sporadic VS.

Study design: Retrospective cohort study.

Setting: Tertiary center.

Patients: We studied 102 patients with sporadic VS diagnosed from 1999 to 2015 with ≥5 years of observation (median, 6.92; interquartile range, 5.85-9.29). Sixty-six patients had AAO-HNS class A/B hearing at presentation and were included in analysis.

Interventions: Audiometry, serial magnetic resonance imaging for observation of VS.

Main outcome measures: Four-frequency pure tone average (PTA) and word recognition scores (WRS) in the VS-affected ear. Decline in high-frequency PTA (average of thresholds at 4000, 6000, and 8,000 Hz) was defined as ≥10 dB during the study period. Decline in WRS was defined as ≥10%.

Results: Compared with those without, patients with progressive HFHL in the non-VS ear were more likely to experience a decline in WRS in the VS ear (80% vs. 54%, p = 0.031). However, the same group showed no difference (52% vs. 41%, p = 0.40) in decline in PTA of the VS ear.

Conclusions: Patients with observed VS who experience progressive HFHL in the non-VS ear are more likely to experience significant declines in speech understanding in the VS-affected ear over time. Patients with a history of presbycusis may have an increased risk of losing serviceable hearing because of sporadic VS.

Publication types

  • Review

MeSH terms

  • Audiometry, Pure-Tone
  • Hearing
  • Humans
  • Neuroma, Acoustic* / complications
  • Presbycusis* / epidemiology
  • Retrospective Studies
  • Treatment Outcome